STVN logo
Stevanato Group S.p.A.(STVN)
$19.77—

Russell 2000 below the 50-day average

Overview →

STVN News

About

founded in 1949, stevanato group is committed to create systems, processes and services that guarantee the integrity of parenteral medicines. it is comprised of two operational divisions: - pharmaceutical systems (ompi and balda brands): specialized in ready-to-use glass containers and bulk primary packaging (syringes, cartridges, vials and ampoules); high quality and high precision plastic solutions for diagnostic, pharmaceutical and medical device applications. - engineering systems (spami, optrel, innoscan and svm brands): specialized in glass forming technology, inspection systems, assembly, packaging machines and serialization solutions for the pharmaceutical industry. these two divisions enjoy a close, synchronous relationship, featuring daily exchanges which ensure that stevanato group has complete control over the entire production process, from purchasing the finest raw materials to offering exceptional after-sales customer service. the group also benefits from the sglab activ

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Franco Moro
Country
Italy
Leadership (7)
Franco StevanatoChief Executive Officer & Executive Chairman
Marco Dal LagoChief Financial Officer
Mauro StocchiChief Business Officer
Michele MonicoPresident of DDS & IVD Business Unit
Raffaele PacePresident of Engineering Business Unit
Carla CostaChief Human Resources Officer
Lisa MilesChief Communications & Investor Relations Officer
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.